These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7042799)

  • 21. Clinical and immunologic evaluation of glutaraldehyde-modified tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trial.
    Metzger WJ; Dorminey HC; Richerson HB; Weiler JM; Donnelly A; Moran D
    J Allergy Clin Immunol; 1981 Dec; 68(6):442-8. PubMed ID: 6796618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immune reactivity to polyvalent monomeric and polymeric ragweed antigens.
    Patterson R; Suszko IM; Zeiss CR; Pruzansky JJ; Bacal E
    J Allergy Clin Immunol; 1978 Jan; 61(1):28-35. PubMed ID: 618944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune response of patients with ragweed hay fever treated with polymerized ragweed antigens.
    Zeiss CR; Ungs CJ; Levitz D; Suszko IM; Patterson R
    J Allergy Clin Immunol; 1979 Apr; 63(4):273-5. PubMed ID: 429704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal polyps: effects of seasonal allergen exposure.
    Keith PK; Conway M; Evans S; Wong DA; Jordana G; Pengelly D; Dolovich J
    J Allergy Clin Immunol; 1994 Mar; 93(3):567-74. PubMed ID: 8151059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local intranasal immunotherapy with high-dose polymerized ragweed extract.
    Georgitis JW; Nickelsen JA; Wypych JI; Barde SH; Clayton WF; Reisman RE
    Int Arch Allergy Appl Immunol; 1986; 81(2):170-3. PubMed ID: 3759259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic and cellular changes accompanying the therapy of pollen allergy.
    Levy DA; Lichtenstein LM; Goldstein EO; Ishizaka K
    J Clin Invest; 1971 Feb; 50(2):360-9. PubMed ID: 4099843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyethylene glycol-modified ragweed pollen extract in rhinoconjunctivitis.
    Juniper EF; Roberts RS; Kennedy LK; O'Connor J; Syty-Golda M; Dolovich J; Hargreave FE
    J Allergy Clin Immunol; 1985 May; 75(5):578-85. PubMed ID: 3989142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.
    Bowen T; Greenbaum J; Charbonneau Y; Hebert J; Filderman R; Sussman G; Del Carpio J; Gold M; Keith P; Moote W; Cecchetto S; Cecchetto O; Sharp D; Broutin O; André C
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):425-30. PubMed ID: 15562880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Amodio FJ; Kagey-Sobotka A; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1982 Feb; 69(2):181-93. PubMed ID: 7056949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of polymerized and unpolymerized antigen E for immunotherapy of ragweed allergy.
    Metzger WJ; Patterson R; Zeiss R; Irons JS; Pruzansky JJ; Suszko IM; Levitz D
    N Engl J Med; 1976 Nov; 295(21):1160-4. PubMed ID: 824555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy.
    Brunet C; Bédard PM; Lavoie A; Jobin M; Hébert J
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):87-94. PubMed ID: 1370511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
    Yunginger JW; Gleich GJ
    J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ragweed immunotherapy in adult asthma.
    Creticos PS; Reed CE; Norman PS; Khoury J; Adkinson NF; Buncher CR; Busse WW; Bush RK; Gadde J; Li JT
    N Engl J Med; 1996 Feb; 334(8):501-6. PubMed ID: 8559203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
    Creticos PS; Maloney J; Bernstein DI; Casale T; Kaur A; Fisher R; Liu N; Murphy K; Nékám K; Nolte H
    J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fraction A: a new immunotherapeutic approach for ragweed pollinosis.
    Bernstein IL; Tennenbaum J; Georgakis N; Kessler F; Krumholz R
    Int Arch Allergy Appl Immunol; 1976; 50(2):181-91. PubMed ID: 1107233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.